Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 12
Submit an article Journal homepage
320
Views
5
CrossRef citations to date
0
Altmetric
Research Article

High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma

Archana VijayDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Qiuli DuanDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Jan-Willem HenningDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Peter DugganDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Andrew DalyDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Mona ShafeyDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
,
Nizar J. BahlisDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada
&
Douglas Allan StewartDepartments of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, CanadaCorrespondence[email protected]
 show all
Pages 2620-2626 | Received 21 Jan 2013, Accepted 03 Mar 2013, Published online: 16 Apr 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Danielle H. Oh, Sunita Ghosh, Neil Chua, Xanthoula Kostaras, Derek Tilley, Michael Chu, Carolyn J. Owen & Douglas A. Stewart. (2015) Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis. Leukemia & Lymphoma 56:6, pages 1756-1762.
Read now
Douglas A. Stewart, Reinhard Kloiber, Carolyn Owen, Nizar J. Bahlis, Peter Duggan, Adnan Mansoor & Isabelle Bence-Bruckler. (2014) Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:9, pages 2064-2070.
Read now

Articles from other publishers (3)

Al-Anazi Khalid Ahmed, A Alshami, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, J Bacal, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, O Albanyan, A Ayyad, Z Alsomali, M Albatran, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, R Alrabeh, F Abu Rahma, F Nightingale, P Ahadai & H Alhashmi. (2023) Outcome of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma and Relapsed and Refractory Hodgkin Lymphoma. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia. Journal of Stem Cell Therapy and Transplantation 7:1, pages 003-015.
Crossref
Vincent H Ha, Sunita Ghosh, Catherine Leyshon, Nikki Ryan, Carole R Chambers & Douglas A Stewart. (2017) Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation. Journal of Oncology Pharmacy Practice 24:5, pages 323-331.
Crossref
Ping Zhou, Peng Liu, Sheng-Yu Zhou, Xiao-Hui He, Xiao-Hong Han, Yan Qin, Sheng Yang, Chang-Gong Zhang, Lin Gui, Jia-Rui Yao, Li-Ya Zhao, Shu-Xiang Zhang, Yan Sun & Yuan-Kai Shi. (2015) Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas. Chinese Medical Journal 128:18, pages 2498-2504.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.